Zinplava Injection, Solution
Product Images NDC 0006-3025

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Zinplava (NDC 0006-3025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (1,000 mg/40 mL Vial Carton)

Zinplava is an injection that contains 1,000mg of bezlotoxumab in 40mL of solution. Each mL of solution contains 25mg bezlotoxumab, ditic acid monohydrate, dithylenetriamine-pentaacetic acid, polysorbate 80, sodium chloride, sodium ditate divydrate, and Water for Injection, USP. It may contain sodium hydroxide to adjust pH to 6.0. Zinplava should be store refrigerated at 2°C-8°C (36°F-46°F) in the original carton to protect from light. It is for intravenous infusion only and requires dilution prior to administration. Each vial is a single-dose vial and unused portions should be discarded. See package insert for details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.